The International Vaccine Institute (IVI) is an international nonprofit organization dedicated to discovering, developing, and delivering safe, effective, and affordable vaccines for global public health. Established in 1997 as an initiative of the United Nations Development Programme (UNDP), IVI works to protect populations, particularly in low- and middle-income countries, from infectious diseases through vaccine research, development, and access programs. Headquartered in Seoul, South Korea, the institute collaborates with governments, research institutions, pharmaceutical companies, and global health organizations worldwide.
History and Background
The concept of the International Vaccine Institute emerged from the Children’s Vaccine Initiative, a global effort aimed at accelerating vaccine development and accessibility. In 1994, the United Nations endorsed the creation of IVI, and the institute was formally established in 1997.
Since its inception, IVI has become one of the world’s leading vaccine-focused international organizations. It has played a crucial role in developing vaccines against cholera, typhoid fever, dengue, and other infectious diseases that disproportionately affect developing countries. Through scientific research and international partnerships, IVI has contributed significantly to reducing the burden of vaccine-preventable diseases globally.
Mission and Purpose
The mission of IVI is to discover, develop, and deliver vaccines for global health, with a particular focus on underserved populations. The institute seeks to bridge the gap between scientific innovation and public health impact by ensuring that life-saving vaccines reach those who need them most.
Its primary objectives include:
- Conducting vaccine research and development
- Supporting vaccine clinical trials
- Strengthening national immunization programs
- Improving vaccine accessibility and affordability
- Building scientific and public health capacity
- Responding to emerging infectious disease threats
Through these efforts, IVI aims to reduce illness, disability, and mortality caused by infectious diseases worldwide.
Governance and Structure
The International Vaccine Institute operates as an independent international organization under treaty status. Member countries and international partners participate in its governance and strategic direction.
The institute is led by a Director General and overseen by a Board of Trustees composed of distinguished experts in public health, medicine, science, policy, and international development. IVI maintains research facilities, technical teams, and collaborative networks that support vaccine development projects across multiple continents.
Its global partnerships include collaborations with governments, universities, research institutes, biotechnology companies, philanthropic foundations, and international organizations.
Funding and Programs
IVI receives funding from a combination of government contributions, international organizations, philanthropic foundations, research grants, and private-sector partnerships.
Vaccine Research and Development
The institute conducts research focused on vaccines for infectious diseases that disproportionately affect vulnerable populations. Areas of focus include cholera, typhoid fever, dengue, chikungunya, COVID-19, and other emerging diseases.
Clinical Development and Trials
IVI supports vaccine evaluation through clinical trials conducted in partnership with research institutions and health authorities around the world. These studies help establish vaccine safety, effectiveness, and regulatory approval pathways.
Vaccine Introduction Programs
The organization assists countries in introducing new vaccines through technical support, policy guidance, disease surveillance, and immunization planning.
Capacity Building
IVI strengthens scientific and public health capacity by training researchers, healthcare professionals, and policymakers in vaccine-related fields.
Major Programs and Achievements
Oral Cholera Vaccine Development
One of IVI’s most recognized achievements is its contribution to the development and global deployment of affordable oral cholera vaccines. These vaccines have been used extensively in outbreak prevention and emergency response programs worldwide.
Typhoid Conjugate Vaccines
IVI played a major role in advancing typhoid conjugate vaccines, helping accelerate their development and introduction in countries with high disease burdens.
Emerging Infectious Diseases Research
The institute actively supports vaccine development efforts targeting emerging health threats and pandemic preparedness initiatives.
Global Health Partnerships
IVI collaborates with organizations such as the World Health Organization, Gavi, the Vaccine Alliance, and Coalition for Epidemic Preparedness Innovations to improve vaccine access and strengthen immunization systems globally.
Impact
Over the past two decades, IVI has helped millions of people gain access to life-saving vaccines. Its research has contributed to reducing disease outbreaks, strengthening public health systems, and improving vaccine availability in some of the world’s most vulnerable communities.
By combining scientific innovation, international cooperation, and public health expertise, IVI continues to play a critical role in advancing global vaccine equity and disease prevention.
Conclusion
The International Vaccine Institute stands as a leading global health organization committed to improving lives through vaccine innovation and accessibility. Through research, development, partnerships, and capacity building, IVI helps ensure that effective vaccines reach populations most in need. Its contributions to global immunization efforts continue to strengthen public health systems and protect communities from infectious diseases worldwide.
For more information, visit here.
